Abstract
Persistent pulmonary hypertension of the newborn (PPHN) contributes significantly to the morbidity and mortality associated with meconium aspiration syndrome. This review article discusses new insights into the vascular abnormalities that are associated with PPHN, including the recent recognition of the importance of oxidant stress in its pathogenesis. Recent data are presented showing that treatment with high oxygen concentrations may increase production of oxygen free radicals. The rationale for the use of inhaled nitric oxide, and strategies for enhancing nitric oxide signaling are discussed. Finally, the rationale for new treatment approaches is reviewed, including inhibition of cyclic guanosine monophosphate-specific phosphodiesterases and scavengers of reactive oxygen species.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Angus DC, Linde-Swirble WT, Clermont G, Griffin MF, Clark RH . Epidemiology of neonatal respiratory failure in the United States. Am J Resp Crit Care Med 2001; 164: 1154–1160.
Farrow KN, Fliman P, Steinhorn RH . The diseases treated with ECMO: focus on PPHN. Semin Perinatol 2005; 29: 8–14.
Shaul PW, Yuhanna IS, German Z, Chen Z, Steinhorn RH, Morin III FC . Pulmonary endothelial NO synthase gene expression is decreased in fetal lambs with pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 1997; 272: L1005–L1012.
Villaneuva ME, Zaher FM, Svinarich DM, Konduri GG . Decreased gene expression of endothelial nitric oxide synthase in newborns with persistent pulmonary hypertension. Pediatr Res 1998; 44: 338–343.
Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. New Engl J Med 1997; 336: 597–604.
Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA et al. Low dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med 2000; 342: 469–474.
Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS). J Pediatr 2000; 136: 611–617.
Clark RH, Huckaby JL, Kueser TJ, Walker MW, Southgate WM, Perez JA et al. Low-dose nitric oxide therapy for persistent pulmonary hypertension: 1-year follow-up. J Perinatol 2003; 23: 300–303.
Konduri GG, Solimani A, Sokol GM, Singer J, Ehrenkranz RA, Singhal N et al. A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure. Pediatrics 2004; 113: 559–564.
Konduri GG, Vohr B, Robertson C, Sokol GM, Solimano A, Singer J et al. Early inhaled nitric oxide therapy for term and near-term newborn infants with hypoxic respiratory failure: neurodevelopmental follow-up. J Pediatr 2007; 150: 235–240.
Fliman PJ, deRegnier RA, Kinsella JP, Reynolds M, Rankin LL, Steinhorn RH . Neonatal extracorporeal life support: impact of new therapies on survival. J Pediatr 2006; 148: 595–599.
Deruelle P, Grover TR, Abman SH . Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheep. Am J Physiol Lung Cell Mol Physiol 2005; 289: L798–L806.
Brennan LA, Steinhorn RH, Wedgwood S, Mata-Greenwood E, Roark EA, Russell JA et al. Increased superoxide generation is associated with pulmonary hypertension in fetal lambs. A role for NADPH oxidase. Circ Res 2003; 92: 683–691.
Wedgwood S, Steinhorn RH, Bunderson M, Wilham J, Lakshminrusimha S, Brennan LA et al. Increased hydrogen peroxide downregulates soluble guanylate cyclase in the lungs of lambs with persistent pulmonary hypertension of the newborn. Am J Physiol Lung Cell Mol Physiol 2005; 289: L660–L666.
Konduri GG, Ou J, Shi Y, Pritchard Jr KA . Decreased association of HSP90 impairs endothelial nitric oxide synthase in fetal lambs with persistent pulmonary hypertension. Am J Physiol Heart Circ Physiol 2003; 285: H204–H211.
Lakshminrusimha S, Russell JA, Steinhorn RH, Ryan RM, Gugino SF, Morin III FC et al. Pulmonary arterial contractility in neonatal lambs increases with 100% oxygen resuscitation. Pediatr Res 2006; 59: 137–141.
Lakshminrusimha S, Russell JA, Steinhorn RH, Swartz DD, Ryan RM, Gugino SF et al. Pulmonary hemodynamics in neonatal lambs resuscitated with 21, 50, and 100% oxygen. Pediatr Res 2007; 62 (3): 313–318.
McNamara PJ, Laique F, Muang-In S, Whyte HE . Milrinone improves oxygenation in neonates with severe persistent pulmonary hypertension of the newborn. J Crit Care 2006; 21: 217–222.
Kelly LK, Porta NF, Goodman DM, Carroll CL, Steinhorn RH . Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr 2002; 141: 830–832.
Shekerdemian L, Ravn H, Penny D . Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Resp Crit Care Med 2002; 165: 1098–2002.
Shekerdemian LS, Ravn HB, Penny DJ . Interaction between inhaled nitric oxide and intravenous sildenafil in a porcine model of meconium aspiration syndrome. Pediatr Res 2004; 55: 413–418.
Atz AM, Wessel DL . Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 1999; 91: 307–310.
Baquero H, Soliz A, Neira F, Venegas ME, Sola A . Oral sildenafil in infants with persistent pulmonary hypertension of the newborn: a pilot randomized blinded study. Pediatrics 2006; 117: 1077–1083.
Steinhorn RH, Albert G, Swartz DD, Russell JA, Levine CR, Davis JM . Recombinant human superoxide dismutase enhances the effect of inhaled nitric oxide in persistent pulmonary hypertension. Am Rev Resp Crit Care Med 2001; 164: 834–839.
Lakshminrusimha S, Russell JA, Wedgwood S, Gugino SF, Kazzaz JA, Davis JM et al. Superoxide dismutase improves oxygenation and reduces oxidation in neonatal pulmonary hypertension. Am J Respir Crit Care Med 2006; 174: 1370–1377.
Author information
Authors and Affiliations
Corresponding author
Additional information
Disclosure
RH Steinhorn has received consulting fees from Ikaria. Grant support from the NIH (HL 54705) supported the research presented in the paper.
Rights and permissions
About this article
Cite this article
Steinhorn, R. Nitric oxide and beyond: new insights and therapies for pulmonary hypertension. J Perinatol 28 (Suppl 3), S67–S71 (2008). https://doi.org/10.1038/jp.2008.158
Published:
Issue Date:
DOI: https://doi.org/10.1038/jp.2008.158
This article is cited by
-
The fetal circulation, pathophysiology of hypoxemic respiratory failure and pulmonary hypertension in neonates, and the role of oxygen therapy
Journal of Perinatology (2016)
-
Thromboxane promotes smooth muscle phenotype commitment but not remodeling of hypoxic neonatal pulmonary artery
Fibrogenesis & Tissue Repair (2015)